Prednisolone Eye Drops
Brand names: Pred Forte (1%), Predsol (0.5%)
Prednisolone eye drops are a topical corticosteroid used to treat ocular inflammation, including anterior uveitis and postoperative or non-infective inflammatory conditions of the eye.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Prednisolone suppresses the inflammatory response by inhibiting multiple inflammatory mediators and reducing capillary permeability and cellular infiltration at the ocular surface and anterior segment.
Prescribing in practice
- Topical ocular corticosteroids can raise intraocular pressure, promote cataract formation and worsen or mask ocular infection (including herpes simplex keratitis and fungal infection), so they should be used under specialist or appropriately experienced supervision and avoided in undiagnosed red eye.
- Prolonged use should be tapered rather than stopped abruptly to reduce rebound inflammation.
- Avoid in active untreated epithelial herpes simplex keratitis and other untreated ocular infections.
Monitoring
Intraocular pressure should be monitored during prolonged use, particularly in patients predisposed to a steroid response or with glaucoma.
Counselling the patient
- Use exactly as directed and do not stop suddenly without advice.
- Report any worsening pain, increasing redness or deteriorating vision promptly.
- Vision may blur briefly after instillation.
Evidence & guidelines
Topical corticosteroids are standard therapy for non-infective anterior segment inflammation, with MHRA and SPC guidance highlighting intraocular pressure and infection risks.
Reference: RCOphth Uveitis Guidelines; NICE Uveitis Pathway; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Steroid Dose Equivalence · Medications
- Maddrey Discriminant Function (Alcoholic Hepatitis) · Alcoholic Liver Disease
- Lille Model (Steroid Response in Alcoholic Hepatitis) · Alcoholic Liver Disease
- Maddrey's Discriminant Function for Alcoholic Hepatitis · Hepatology
- Lille Model for Alcoholic Hepatitis · Hepatology
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme